Skip to main content
Erschienen in: Supportive Care in Cancer 12/2005

01.12.2005 | Original Article

The relationship between fatigue and light exposure during chemotherapy

verfasst von: Lianqi Liu, Matthew R. Marler, Barbara A. Parker, Vicky Jones, Sherella Johnson, Mairav Cohen-Zion, Lavinia Fiorentino, Georgia Robins Sadler, Sonia Ancoli-Israel

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

Fatigue is one of the most common and distressing complaints among cancer patients, not only during radiation and chemotherapy, but also for months to years after the completion of treatment. Fatigue interferes with patients’ daily lives, reduces their quality of life, and is often a significant reason why patients discontinue treatment. We hypothesized that some of the fatigue may be related to disrupted circadian rhythms and low light exposure. The main objective of this study therefore was to investigate the association between fatigue and light exposure among patients with breast cancer.

Methods

As part of a larger, ongoing prospective study on fatigue, sleep, and circadian rhythms in patients with breast cancer, an analysis of 63 women newly diagnosed with stage I–IIIA breast cancer and scheduled to receive four cycles of adjuvant or neoadjuvant anthracycline-based chemotherapy was conducted. Data were collected before and during weeks 1, 2, and 3 of cycle 1 and cycle 4. Fatigue was assessed using the Short Form of Multidimensional Fatigue Symptom Inventory. Light exposure was recorded with a wrist actigraph.

Results

There were significant correlations between fatigue levels and light exposure (r=−0.28 to −0.45) within both cycle 1 and cycle 4, such that higher levels of fatigue were associated with less light exposure. There were also significant correlations between changes in light exposure and changes in fatigue within the first 2 weeks of each cycle (r=−0.28 to −0.52).

Conclusions

Increased fatigue was significantly correlated with decreased light exposure among patients with breast cancer. Although the cause and effect of exacerbated fatigue and decreased light exposure cannot be confirmed by the current study, and lower light exposure may just in part be due to the fatigued patients spending less time outdoors in bright light, two hypotheses are proposed about the mechanisms by which light may alleviate the fatigue of patients with breast cancer. These results suggest the need for prospective intervention studies of light therapy for breast-cancer-related fatigue.
Literatur
1.
Zurück zum Zitat Winningham ML, Nail LM, Burke MB, Brophy L, Cimprich B, Jones LS, Pickard-Holley S, Rhodes V, St. Pierre B, Beck S, Glass EC, Mock VL, Mooney KH, Piper B (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21:23–36PubMed Winningham ML, Nail LM, Burke MB, Brophy L, Cimprich B, Jones LS, Pickard-Holley S, Rhodes V, St. Pierre B, Beck S, Glass EC, Mock VL, Mooney KH, Piper B (1994) Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 21:23–36PubMed
2.
Zurück zum Zitat Morrow GR, Andrews PLR, Hickok JT, Roscoe JA, Matteson S (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10:389–398CrossRefPubMed Morrow GR, Andrews PLR, Hickok JT, Roscoe JA, Matteson S (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10:389–398CrossRefPubMed
3.
Zurück zum Zitat Smets EMA, Garssen B, Schuster-Uitterhoeve AL, de Haes JC (1993) Fatigue in cancer patients. Br J Cancer 68:220–224PubMed Smets EMA, Garssen B, Schuster-Uitterhoeve AL, de Haes JC (1993) Fatigue in cancer patients. Br J Cancer 68:220–224PubMed
4.
Zurück zum Zitat Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20–32 Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4:20–32
5.
Zurück zum Zitat de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25:283–297CrossRefPubMed de Jong N, Courtens AM, Abu-Saad HH, Schouten HC (2002) Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 25:283–297CrossRefPubMed
6.
Zurück zum Zitat Lindley C, Vasa S, Sawyer WT, Winer EP (1998) Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16:1380–1387PubMed Lindley C, Vasa S, Sawyer WT, Winer EP (1998) Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 16:1380–1387PubMed
7.
Zurück zum Zitat Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753PubMed
7a.
Zurück zum Zitat Ancoli-Israel S, Parker BA, Marler M, Sadler GR, Jones V, Liu L (2004) Fatigue, sleep and circadian rhythms prior to chemotherapy in breast cancer. Breast Cancer Res Treat 8(Suppl 1) abstract Ancoli-Israel S, Parker BA, Marler M, Sadler GR, Jones V, Liu L (2004) Fatigue, sleep and circadian rhythms prior to chemotherapy in breast cancer. Breast Cancer Res Treat 8(Suppl 1) abstract
8.
Zurück zum Zitat Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18:233–242CrossRefPubMed Jacobsen PB, Hann DM, Azzarello LM, Horton J, Balducci L, Lyman GH (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18:233–242CrossRefPubMed
9.
Zurück zum Zitat Cimprich B (1999) Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 22:185–194CrossRefPubMed Cimprich B (1999) Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs 22:185–194CrossRefPubMed
10.
Zurück zum Zitat Visser MRM, Smets EMA (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6:101–108CrossRefPubMed Visser MRM, Smets EMA (1998) Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer 6:101–108CrossRefPubMed
11.
Zurück zum Zitat Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183CrossRefPubMed Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, Clemons M, Crump M, Goss PE, Warr D, Tweedale ME, Tannock IF (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21:4175–4183CrossRefPubMed
12.
Zurück zum Zitat Ancoli-Israel S, Moore P, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10:245–255CrossRef Ancoli-Israel S, Moore P, Jones V (2001) The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10:245–255CrossRef
13.
Zurück zum Zitat Jacobsen PB, Stein K (1999) Is fatigue a long-term side effect of breast cancer treatment? Cancer Control 6:256–263PubMed Jacobsen PB, Stein K (1999) Is fatigue a long-term side effect of breast cancer treatment? Cancer Control 6:256–263PubMed
14.
Zurück zum Zitat Remick RA (2002) Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 167:1253–1260PubMed Remick RA (2002) Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 167:1253–1260PubMed
15.
Zurück zum Zitat Prasko J, Horacek J, Klaschka J, Kosova J, Ondrackova I, Sipek J (2002) Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuroendocrinol Lett 23:109–113PubMed Prasko J, Horacek J, Klaschka J, Kosova J, Ondrackova I, Sipek J (2002) Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression. Neuroendocrinol Lett 23:109–113PubMed
16.
Zurück zum Zitat Kripke DF (1998) Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J Affect Disord 49:109–117CrossRefPubMed Kripke DF (1998) Light treatment for nonseasonal depression: speed, efficacy, and combined treatment. J Affect Disord 49:109–117CrossRefPubMed
17.
Zurück zum Zitat Dijk DJ, Boulos Z, Eastman CI, Lewy AJ, Campbell SS, Terman M (1995) Light treatment for sleep disorders: consensus report. II. Basic properties of circadian physiology and sleep regulation. J Biol Rhythms 10:113–125PubMed Dijk DJ, Boulos Z, Eastman CI, Lewy AJ, Campbell SS, Terman M (1995) Light treatment for sleep disorders: consensus report. II. Basic properties of circadian physiology and sleep regulation. J Biol Rhythms 10:113–125PubMed
18.
Zurück zum Zitat Terman M, Lewy AJ, Dijk DJ, Boulos Z, Eastman CI, Campbell SS (1995) Light treatment for sleep disorders: consensus report. IV. Sleep phase and duration disturbances. J Biol Rhythms 10:135–147PubMed Terman M, Lewy AJ, Dijk DJ, Boulos Z, Eastman CI, Campbell SS (1995) Light treatment for sleep disorders: consensus report. IV. Sleep phase and duration disturbances. J Biol Rhythms 10:135–147PubMed
19.
Zurück zum Zitat Eastman CI, Boulos Z, Terman M, Campbell SS, Dijk DJ, Lewy AJ (1995) Light treatment for sleep disorders: consensus report. VI. Shift work. J Biol Rhythms 10:157–164PubMed Eastman CI, Boulos Z, Terman M, Campbell SS, Dijk DJ, Lewy AJ (1995) Light treatment for sleep disorders: consensus report. VI. Shift work. J Biol Rhythms 10:157–164PubMed
20.
Zurück zum Zitat Boulos Z, Campbell SS, Lewy AJ, Terman M, Dijk DJ, Eastman CI (1995) Light treatment for sleep disorders: consensus report. VII. Jet lag. J Biol Rhythms 10:167–176PubMed Boulos Z, Campbell SS, Lewy AJ, Terman M, Dijk DJ, Eastman CI (1995) Light treatment for sleep disorders: consensus report. VII. Jet lag. J Biol Rhythms 10:167–176PubMed
21.
Zurück zum Zitat Stein KD, Martin SC, Hann DM, Jacobsen PB (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6:143–152CrossRefPubMed Stein KD, Martin SC, Hann DM, Jacobsen PB (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6:143–152CrossRefPubMed
22.
Zurück zum Zitat Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the multidimensional fatigue symptom inventory—short form. J Pain Symptom Manage 27:14–23CrossRefPubMed Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the multidimensional fatigue symptom inventory—short form. J Pain Symptom Manage 27:14–23CrossRefPubMed
23.
Zurück zum Zitat Ancoli-Israel S, Cole R, Alessi CA, Chambers M, Moorcroft WH, Pollak C (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26:342–392PubMed Ancoli-Israel S, Cole R, Alessi CA, Chambers M, Moorcroft WH, Pollak C (2003) The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26:342–392PubMed
24.
Zurück zum Zitat Cole RJ, Kripke DF, Gruen W, Nava J (1990) Ambulatory monitoring of light exposure: comparison of measurements at forehead and wrist. Sleep Res 19:364 Cole RJ, Kripke DF, Gruen W, Nava J (1990) Ambulatory monitoring of light exposure: comparison of measurements at forehead and wrist. Sleep Res 19:364
25.
Zurück zum Zitat SAS Institute Inc (1999) SAS/STAT user’s guide, version 8. 1–3884 SAS Institute Inc (1999) SAS/STAT user’s guide, version 8. 1–3884
26.
Zurück zum Zitat Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25:51–62PubMed Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 25:51–62PubMed
27.
Zurück zum Zitat Schwartz AL (2000) Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract 8:16–24CrossRefPubMed Schwartz AL (2000) Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract 8:16–24CrossRefPubMed
28.
Zurück zum Zitat Küller R (2002) The influence of light on circarhythms in humans. J Physiol Anthropol Appl Hum Sci 21:87–91CrossRef Küller R (2002) The influence of light on circarhythms in humans. J Physiol Anthropol Appl Hum Sci 21:87–91CrossRef
29.
Zurück zum Zitat Berger AM, Farr L (1999) The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 26:1663–1671PubMed Berger AM, Farr L (1999) The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 26:1663–1671PubMed
30.
Zurück zum Zitat Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PLR (2002) Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 10:329–336CrossRefPubMed Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PLR (2002) Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 10:329–336CrossRefPubMed
31.
Zurück zum Zitat Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR (2002) Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriat Soc 50:282–289CrossRefPubMed Ancoli-Israel S, Martin JL, Kripke DF, Marler M, Klauber MR (2002) Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriat Soc 50:282–289CrossRefPubMed
32.
Zurück zum Zitat Ancoli-Israel S, Gehrman PR, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L (2003) Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med 1:22–36CrossRefPubMed Ancoli-Israel S, Gehrman PR, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L (2003) Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med 1:22–36CrossRefPubMed
33.
Zurück zum Zitat Magnusson A, Boivin D (2003) Seasonal affective disorder: an overview. Chronobiol Int 20:189–207CrossRefPubMed Magnusson A, Boivin D (2003) Seasonal affective disorder: an overview. Chronobiol Int 20:189–207CrossRefPubMed
34.
Zurück zum Zitat Zubieta JK, Engleberg NC, Yargic LI, Pande AC, Demitrack MA (1994) Seasonal symptom variation in patients with chronic fatigue—comparison with major mood disorders. J Psychiatr Res 28:13–22CrossRefPubMed Zubieta JK, Engleberg NC, Yargic LI, Pande AC, Demitrack MA (1994) Seasonal symptom variation in patients with chronic fatigue—comparison with major mood disorders. J Psychiatr Res 28:13–22CrossRefPubMed
Metadaten
Titel
The relationship between fatigue and light exposure during chemotherapy
verfasst von
Lianqi Liu
Matthew R. Marler
Barbara A. Parker
Vicky Jones
Sherella Johnson
Mairav Cohen-Zion
Lavinia Fiorentino
Georgia Robins Sadler
Sonia Ancoli-Israel
Publikationsdatum
01.12.2005
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0824-5

Weitere Artikel der Ausgabe 12/2005

Supportive Care in Cancer 12/2005 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.